Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(1R,2S,3R,5S)-3-(7-(((2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol is an intermediate of (T437700). Ticagrelor, the first reversible oral P2Y12 receptor antagonist that provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel.
?您的位置：
